BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Park SY, Gong HS, Kim KM, Kim D, Kim HY, Jeon CH, Ju JH, Lee SS, Park DA, Sung YK, Kim SW. Korean Guideline for the Prevention and Treatment of Glucocorticoid-induced Osteoporosis. J Bone Metab 2018;25:195-211. [PMID: 30574464 DOI: 10.11005/jbm.2018.25.4.195] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Cho YY, Chung YJ. Vitamin D supplementation does not prevent the recurrence of Graves' disease. Sci Rep 2020;10:16. [PMID: 31913301 DOI: 10.1038/s41598-019-55107-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
2 Leipe J, Holle JU, Weseloh C, Pfeil A, Krüger K. German Society of Rheumatology recommendations for management of glucocorticoid-induced osteoporosis. Z Rheumatol 2021. [PMID: 34705070 DOI: 10.1007/s00393-021-01025-z] [Reference Citation Analysis]
3 Nam B, Sung YK, Choi CB, Kim TH, Jun JB, Bae SC, Yoo DH, Cho SK. Fracture Risk and Its Prevention Patterns in Korean Patients with Polymyalgia Rheumatica: a Retrospective Cohort Study. J Korean Med Sci 2021;36:e263. [PMID: 34697929 DOI: 10.3346/jkms.2021.36.e263] [Reference Citation Analysis]
4 Wang J, Li H. Treatment of Glucocorticoid-Induced Osteoporosis with Bisphosphonates Alone, Vitamin D Alone or a Combination Treatment in Eastern Asians: A Meta-Analysis. Curr Pharm Des 2019;25:1653-62. [PMID: 31218954 DOI: 10.2174/1381612825666190619125426] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Ha JH, Kim HS, Won SJ, Lee YK, Koo KH. Physicians' Attitudes on Management of Osteopenia in South Korea. J Bone Metab 2020;27:201-5. [PMID: 32911584 DOI: 10.11005/jbm.2020.27.3.201] [Reference Citation Analysis]
6 Iki M, Fujimori K, Nakatoh S, Tamaki J, Ishii S, Okimoto N, Kamiya K, Ogawa S. Guideline adherence by physicians for management of glucocorticoid-induced osteoporosis in Japan: a nationwide health insurance claims database study. Osteoporos Int 2022. [PMID: 35022812 DOI: 10.1007/s00198-021-06265-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Leipe J, Holle JU, Weseloh C, Pfeil A, Krüger K; die Kommission Pharmakotherapie der Deutschen Gesellschaft für Rheumatologie e. V. (DGRh). [German Society of Rheumatology Recommendations for the management of glucocorticoid-induced Osteoporosis. German version]. Z Rheumatol 2021;80:670-87. [PMID: 34357436 DOI: 10.1007/s00393-021-01028-w] [Reference Citation Analysis]
8 Kim JH, Seo BK, Baek YH. Quality assessment of traditional and conventional medicine clinical practice guidelines for osteoporosis. Medicine (Baltimore) 2021;100:e24559. [PMID: 33592911 DOI: 10.1097/MD.0000000000024559] [Reference Citation Analysis]
9 Tang X, Gao Y, Chen Y, Li X, Yu P, Ma Z, Liu R. Evaluation of the effect of CaD on the bone structure and bone metabolic changes in senile osteoporosis rats based on MLP–ANN methods. Food Funct 2019;10:8026-41. [DOI: 10.1039/c9fo01322a] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Yu Y, Lv L, Yin SL, Chen C, Jiang S, Zhou PZ. Clivus-involved immunoglobulin G4 related hypertrophic pachymeningitis mimicking meningioma: A case report. World J Clin Cases 2022; 10(18): 6269-6276 [DOI: 10.12998/wjcc.v10.i18.6269] [Reference Citation Analysis]
11 Chotiyarnwong P, McCloskey EV. Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment. Nat Rev Endocrinol 2020;16:437-47. [PMID: 32286516 DOI: 10.1038/s41574-020-0341-0] [Cited by in Crossref: 93] [Cited by in F6Publishing: 71] [Article Influence: 46.5] [Reference Citation Analysis]
12 Soen S, Kaku M, Okubo N, Onishi Y, Saito K, Kobayashi M. Fracture risk associated with glucocorticoid-induced osteoporosis in Japan. J Bone Miner Metab 2022. [PMID: 35546370 DOI: 10.1007/s00774-022-01325-7] [Reference Citation Analysis]
13 Kwon OC, Oh JS, Park MC, Kim YG. Effect of Vitamin D Supplementation on Bone Mineral Density in Rheumatoid Arthritis Patients With Osteoporosis. Front Med (Lausanne) 2020;7:443. [PMID: 32974365 DOI: 10.3389/fmed.2020.00443] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Cho SK, Sung YK. Update on Glucocorticoid Induced Osteoporosis. Endocrinol Metab (Seoul) 2021;36:536-43. [PMID: 34107602 DOI: 10.3803/EnM.2021.1021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Lee KA, Kim J, Kim HJ, Kim HS. Discriminative ability of trabecular bone score over bone mineral density for vertebral and fragility fracture in patients treated with long-term and low-dose glucocorticoid. Int J Rheum Dis 2021;24:1053-60. [PMID: 34184827 DOI: 10.1111/1756-185X.14164] [Reference Citation Analysis]
16 Cho JH, Min TH, Chun DI, Won SH, Park SY, Kim K, Yi Y. Bone Mineral Density in Diabetes Mellitus Foot Patients for Prediction of Diabetic Neuropathic Osteoarthropathic Fracture. J Bone Metab 2020;27:207-15. [PMID: 32911585 DOI: 10.11005/jbm.2020.27.3.207] [Reference Citation Analysis]
17 Soen S, Kaku M, Okubo N, Touzeni S, Saito K, Kobayashi M. Epidemiology of glucocorticoid-induced osteoporosis and management of associated fracture risk in Japan. J Bone Miner Metab 2021. [PMID: 34125296 DOI: 10.1007/s00774-021-01236-z] [Reference Citation Analysis]
18 Agarwal A, Adachi JD. Therapies for Preventing Bone Loss with Glucocorticoid Treatment. Curr Osteoporos Rep 2021;19:34-9. [PMID: 33409989 DOI: 10.1007/s11914-020-00653-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Lee TH, Song YJ, Kim H, Sung YK, Cho SK. Intervention Thresholds for Treatment in Patients with Glucocorticoid-Induced Osteoporosis: Systematic Review of Guidelines. J Bone Metab 2020;27:247-59. [PMID: 33317228 DOI: 10.11005/jbm.2020.27.4.247] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
20 Burden AM, Tanaka Y, Xu L, Ha YC, McCloskey E, Cummings SR, Glüer CC. Osteoporosis case ascertainment strategies in European and Asian countries: a comparative review. Osteoporos Int 2021;32:817-29. [PMID: 33305343 DOI: 10.1007/s00198-020-05756-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]